These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 35547449)
1. Acute Multiple Sclerosis Exacerbation After Vaccination With the Johnson & Johnson COVID-19 Vaccine: Novel Presentation and First Documented Case Report. Al-Midfai Y; Kujundzic W; Uppal S; Oakes D; Giezy S Cureus; 2022 Apr; 14(4):e24017. PubMed ID: 35547449 [TBL] [Abstract][Full Text] [Related]
2. Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series. Quintanilla-Bordás C; Gascón-Gimenez F; Alcalá C; Payá M; Mallada J; Silla R; Carratalà-Boscà S; Gasque-Rubio R; Castillo J; Casanova B Front Neurol; 2022; 13():897275. PubMed ID: 35572939 [TBL] [Abstract][Full Text] [Related]
3. A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination. Ahoussougbemey Mele A; Ogbuagu H; Parag S; Pierce B Cureus; 2022 Dec; 14(12):e32799. PubMed ID: 36694492 [TBL] [Abstract][Full Text] [Related]
5. A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination. Morehouse ZP; Paulus A; Jasti SA; Bing X Cureus; 2021 Sep; 13(9):e18153. PubMed ID: 34703690 [TBL] [Abstract][Full Text] [Related]
6. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735 [TBL] [Abstract][Full Text] [Related]
7. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Achiron A; Dolev M; Menascu S; Zohar DN; Dreyer-Alster S; Miron S; Shirbint E; Magalashvili D; Flechter S; Givon U; Guber D; Stern Y; Polliack M; Falb R; Gurevich M Mult Scler; 2021 May; 27(6):864-870. PubMed ID: 33856242 [TBL] [Abstract][Full Text] [Related]
9. Multiple Sclerosis Relapse Following COVID-19 Vaccination: A Case Report and Literature Review. Kataria S; Rogers S; Bilal U; Baktashi H; Singh R Cureus; 2022 Jan; 14(1):e21374. PubMed ID: 35198286 [TBL] [Abstract][Full Text] [Related]
10. Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination. Czarnowska A; Kapica-Topczewska K; Tarasów E; Tarasiuk J; Chorąży M; Kochanowicz J; Kułakowska A Front Neurol; 2023; 14():1097799. PubMed ID: 36873437 [TBL] [Abstract][Full Text] [Related]
11. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723 [TBL] [Abstract][Full Text] [Related]
12. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations. Kounis NG; Koniari I; de Gregorio C; Velissaris D; Petalas K; Brinia A; Assimakopoulos SF; Gogos C; Kouni SN; Kounis GN; Calogiuri G; Hung MY Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807579 [TBL] [Abstract][Full Text] [Related]
13. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. Thuluvath PJ; Robarts P; Chauhan M J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination associated severe immune thrombocytopenia. Shah SRA; Dolkar S; Mathew J; Vishnu P Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487 [TBL] [Abstract][Full Text] [Related]
15. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
16. Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases. Nistri R; Barbuti E; Rinaldi V; Tufano L; Pozzilli V; Ianniello A; Marinelli F; De Luca G; Prosperini L; Tomassini V; Pozzilli C Front Neurol; 2021; 12():765954. PubMed ID: 34744992 [No Abstract] [Full Text] [Related]
17. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. Shazley O; Alshazley M Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937 [TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy. Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]